CSL Seqirus and Toll team members at CSL Seqirus' facility next to Toll's soon-to-be-constructed Tullamarine warehouse and distribution centreLogistics company Toll Group is building a 10,000 sqm warehouse and distribution centre in Melbourne to support vaccine maker CSL Seqirus.
Toll’s warehouse, which will be built next to CSL Seqirus’ manufacturing site in the Melbourne suburb of Tullamarine, is due to commence operations in August.
CSL Seqirus’ soon-to-be-completed biotech plant will supply influenza vaccines to Australia and the rest of the world.
The state-of-the-art facility will use innovative cell-based technology to produce influenza vaccines for use in both influenza pandemics and seasonal vaccination programs and will be the only cell-based influenza vaccine manufacturing facility in the Southern Hemisphere.
Toll’s facility will handle both finished goods distribution and supply raw materials and packaging to the CSL Seqirus plant.
"We are proud to strengthen our partnership with CSL Seqirus and expand our footprint in the healthcare logistics sector," says Perry Singh, Toll’s president, government and defence.
"This new facility exemplifies our commitment to delivering high-quality, tailored supply chain solutions to meet the evolving needs of our customers."